Literature DB >> 11076829

Ischemic inactivation of G protein-coupled receptor kinase and altered desensitization of canine cardiac beta-adrenergic receptors.

X Yu1, M Zhang, K Kyker, E Patterson, J L Benovic, D C Kem.   

Abstract

BACKGROUND: G protein-coupled receptor kinases (GRKs) modulate myocardial beta-adrenergic receptor (betaAR) signaling. We examined whether GRK activity was altered 6, 24, and 96 hours after left anterior descending coronary artery ligation (LAD CAL) in the dog. METHODS AND
RESULTS: GRK activity was measured in arrhythmogenic subepicardial border zone (EBZ) tissue overlying the infarct and from nonischemic remote-site (RS) subepicardial tissue from the same animal. GRK activity in the ischemic EBZ was 15% of RS (P:=0.03, n=6) 24 hours after CAL and appeared to start as early as 6 hours through 96 hours. GRK activity and immunoblot data demonstrated a marked decrease of GRK2 but not GRK5 at 24 hours. EBZ tissue exhibited high-affinity binding for (-)-isoproterenol (K:(i) of 0. 076+/-0.026 nmol/L [SEM]) at 24 hours, which was not significantly different from control tissue from nonoperated animals (1.2+/-0.8 nmol/L, P:>0.05, n=6). A significantly lower K:(i) of 13.8+/-2.8 nmol/L (P:<0.001, n=6) was observed for RS taken from the ischemic animals. This was reflected by a 4-fold increase in the EC(50) of isoproterenol-stimulated adenylyl cyclase activity from 18 nmol/L in EBZ tissue to 73 nmol/L in RS (P:<0.05, n=4).
CONCLUSIONS: There is a selective decrease in GRK2 activity and a loss of the ability of the arrhythmia-prone EBZ tissue to desensitize to beta-adrenergic stimulation 24 hours after CAL. This correlates temporally with a second (late) peak in sudden cardiac death previously observed between 6 and 24 hours in dog and rat models of myocardial infarction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11076829     DOI: 10.1161/01.cir.102.20.2535

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  The role of mutant protein level in autosomal recessive catecholamine dependent polymorphic ventricular tachycardia (CPVT2).

Authors:  Guy Katz; Asher Shainberg; Edith Hochhauser; Efrat Kurtzwald-Josefson; Ahuva Issac; Dalia El-Ani; Dan Aravot; Arnon Afek; Jonathan G Seidman; Christine E Seidman; Michael Eldar; Michael Arad
Journal:  Biochem Pharmacol       Date:  2013-09-23       Impact factor: 5.858

2.  Independent contribution of catecholamines to arrhythmogenesis during evolving infarction in the isolated rat heart.

Authors:  Hugh Clements-Jewery; David J Hearse; Michael J Curtis
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

3.  Association of Admission Glycaemia With High Grade Atrioventricular Block in ST-Segment Elevation Myocardial Infarction Undergoing Reperfusion Therapy: An Observational Study.

Authors:  Bi Huang; Xinjie Wang; Yanmin Yang; Jun Zhu; Yan Liang; Huiqiong Tan; Litian Yu; Xin Gao; Han Zhang; Juan Wang
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.889

Review 4.  G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases.

Authors:  Cristina Murga; Alba C Arcones; Marta Cruces-Sande; Ana M Briones; Mercedes Salaices; Federico Mayor
Journal:  Front Pharmacol       Date:  2019-02-19       Impact factor: 5.810

5.  Degradation of GRK2 and AKT is an early and detrimental event in myocardial ischemia/reperfusion.

Authors:  Petronila Penela; Javier Inserte; Paula Ramos; Antonio Rodriguez-Sinovas; David Garcia-Dorado; Federico Mayor
Journal:  EBioMedicine       Date:  2019-10-05       Impact factor: 8.143

6.  The role of G protein coupled receptor kinases in neurocardiovascular pathophysiology.

Authors:  Tijana Bojic; Emina Sudar; Dimitri Mikhailidis; Dragan Alavantic; Esma Isenovic
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.